Home
>
Chemical Reagents>Impurities>Organic Building Blocks>
>
Deschloroethyl Bendamustine Hydrochloride
For research use only. Not for therapeutic Use.
Deschloroethyl Bendamustine Hydrochloride (CAT: C000126) is an impurity that can be formed during the synthesis of Bendamustine. Bendamustine is a chemotherapy drug used to treat various types of cancer, including lymphoma and leukemia. Monitoring and controlling the levels of impurities like Deschloroethyl Bendamustine Hydrochloride during the synthesis process is critical to ensure the purity and safety of the final pharmaceutical product.
Catalog Number | C000126 |
CAS Number | 1797881-48-1 |
Synonyms | 5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid; 4-[5-(2-Chloroethylamino)-1-methylbenzimidazol-2-yl]butanoic Acid; |
Molecular Formula | C₁₄H₁₉Cl₂N₃O₂ |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | White to Pale Orange Solid |
Storage | -20°C, Hygroscopic |
Reference | Bremer, K., et al.: Tumordiagn. Ther., 17, 1 (1996); Barman Balfour, J.A., et al.: Drugs, 61, 631 (2001); |